Trials / Sponsors / Seaport Therapeutics
Seaport Therapeutics
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants W Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | Phase 2 | 2025-09-02 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disor Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | Phase 2 | 2025-06-19 |